Savior Lifetec Corporation announced on Dec 17, 2014 that the active pharmaceutical ingredient(API) manufacturing facility in Chunan, Taiwan has been granted "acceptable" status under the FDA's regulatory guidelines. The cGMP inspection by the US Food and Drug Administration (FDA) was completed during the period of May 19-23, 2014.